Pixie Dust Technologies Announces Launch of VUEVO Display
NEW YORK and TOKYO, Aug. 2, 2024 /PRNewswire/ - Pixie Dust Technologies, Inc. (Nasdaq: PXDT) (the "Company"), a Japanese technology company focused...
Month: August 2024
Perella Weinberg Reports Second Quarter 2024 Results
Financial Overview - Second QuarterFinancial Overview - First HalfTalent InvestmentCapital ManagementRead more at globenewswire.com
Priority Technology Holdings, Inc. Announces Second Quarter 2024 Financial Results Release Date and Conference Call Information
Contacts Priority Investor Inquiries: Chris Kettmann chris.kettmann@dgagroup.com (773) 497-7575 Priority Technology Holdings, Inc. (NASDAQ: PRTH) (“Priority” or the “Company”), the...
PainReform’s New Manufacturing Process Achieves Significant Benefits Including 18-Month Stability of PRF-110 at Room Temperature
TEL AVIV, Israel, Aug. 01, 2024 (GLOBE NEWSWIRE) -- PainReform Ltd. (Nasdaq: PRFX) ("PainReform" or the "Company"), a clinical-stage specialty...
ParkOhio Announces Second Quarter 2024 Results Webcast
Contacts MATTHEW V. CRAWFORD PARK-OHIO HOLDINGS CORP. (440) 947-2000 ParkOhio (NASDAQ: PKOH) announces the following webcast: What: ParkOhio (NASDAQ: PKOH)...
Phunware Announces Earnings Release Date and Live Conference Call for Second Quarter 2024 Financial Results
AUSTIN, Texas, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Phunware, Inc. (“Phunware” or the “Company”) (NASDAQ: PHUN), the mobile experience platform...
PDS Biotech Aligns with FDA on Phase 3 Trial in HPV16-Positive First-Line Recurrent or Metastatic Head and Neck Cancer
Company to initiate Phase 3 VERSATILE-003 trial in Q4 2024Conference Call Today at 8:00 a.m. Eastern TimePRINCETON, N.J., Aug. 01,...
Syntec Optics (Nasdaq: OPTX) Launches Production of New Disposable Optics for Characterization of Biomolecules and Nanoparticles
ROCHESTER, NEW YORK, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Syntec Optics, a leading provider of mission-critical optics for scientific and...
Oncolytics Biotech® to Participate in a Fireside Chat at Canaccord Genuity’s 44th Annual Growth Conference
SAN DIEGO and CALGARY, AB, Aug. 2, 2024 /PRNewswire/ -- Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing...
Okta to Announce Second Quarter Fiscal Year 2025 Financial Results on August 28, 2024
Contacts Investor Contact: Dave Gennarelli investor@okta.com Media Contact: Kyrk Storer press@okta.com Okta, Inc. (NASDAQ: OKTA), the leading independent identity partner,...
Navitas Powers AI and EVs with Gen-3 ‘Fast’ SiC in Robust TOLL Package
TORRANCE, Calif., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Navitas Semiconductor (Nasdaq: NVTS), the industry leader in next-generation GaNFast™ gallium nitride...
Charles & Dean Finance Subscribe to Appex Now Products Flex and Dock
ENCINO, Calif., Aug. 01, 2024 (GLOBE NEWSWIRE) -- NETSOL Technologies, Inc. (Nasdaq: NTWK), a global leader in delivering state-of-the-art solutions for the...
Intellia Therapeutics to Hold Conference Call to Discuss Second Quarter 2024 Earnings and Company Updates
CAMBRIDGE, Mass., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on...
Insight Enterprises, Inc. Reports Second Quarter Results
Contacts GLYNIS BRYAN CHIEF FINANCIAL OFFICER TEL. 480.333.3390 EMAIL glynis.bryan@insight.com Insight Enterprises, Inc. (NASDAQ: NSIT) (the “Company”) today reported financial...
NICE Actimize Wins 2024 RegTech Insight Awards APAC for “Best Transaction Monitoring Solution”
The award acknowledged NICE Actimize’s Suspicious Activity Monitoring solution and its ability to address regulatory problems facing the Asia-Pacific market...
Nephros Schedules Second Quarter 2024 Financial Results Conference Call
SOUTH ORANGE, NJ, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration...
NaaS Technology Inc. Releases 2023 Environmental, Social and Governance Report
BEIJING, Aug. 2, 2024 /PRNewswire/ -- NaaS Technology Inc. ("NaaS" or the "Company") (Nasdaq: NaaS), the first U.S. listed EV...
MACOM Reports Fiscal Third Quarter 2024 Financial Results
Contacts Company Contact: MACOM Technology Solutions Holdings, Inc. Stephen Ferranti Vice President, Corporate Development and Investor Relations P: 978-656-2977 E:...
Maris-Tech Secures a $700,000 Order from a Repeat Customer in the Defense Industry for Innovative AI-Based Video Distribution Solution
The customized high-end system will be designed for integration on armored vehiclesRehovot, Israel, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Maris-Tech...
Maris-Tech Secures a $700,000 Order from a Repeat Customer in the Defense Industry for Innovative AI-Based Video Distribution Solution
The customized high-end system will be designed for integration on armored vehiclesRehovot, Israel, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Maris-Tech...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates HMNF, MORF, BALY on Behalf of Shareholders
NEW YORK, Aug. 1, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies...
Monro, Inc. to Participate at the J.P. Morgan Auto Conference
Contacts Investors and Media: Felix Veksler Senior Director, Investor Relations ir@monro.com Monro, Inc. (Nasdaq: MNRO), a leading provider of automotive...
Monogram Technologies to Host Second Quarter 2024 Business Update Conference Call on Wednesday, August 14, 2024 at 4:30 p.m. Eastern Time
AUSTIN, TX / ACCESSWIRE / August 1, 2024 / Monogram Technologies Inc. (NASDAQ:MGRM) ("Monogram" or the "Company"), an AI-driven robotics...
MGP Ingredients Reports Second Quarter 2024 Results
ATCHISON, Kan., Aug. 01, 2024 (GLOBE NEWSWIRE) -- MGP Ingredients, Inc. (Nasdaq: MGPI), a leading provider of branded and distilled spirits...
Madrigal Pharmaceuticals Appoints Shannon Kelley as General Counsel
CONSHOHOCKEN, Pa., Aug. 02, 2024 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics...
Moleculin Announces Plans for MIRACLE Phase 3 Pivotal Trial
Based on an encouraging discussion in the End of Phase 1B/2 Meeting with FDA the Company plans to: Proceed with...
Microbot Medical and Emory University to Evaluate the Future Autonomous Capabilities of the LIBERTY® Endovascular Robotic Surgical System
BRAINTREE, Mass., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) today announced it has entered into an...
MARRIOTT INTERNATIONAL SIGNS AGREEMENT WITH ZHONG AN COMMERCIAL GROUP TO BRING W HOTELS TO HANGZHOU
SHANGHAI, Aug. 1, 2024 /PRNewswire/ -- Marriott International, Inc. recently announced that it has signed an agreement with Zhong An...
Lantern Pharma to Report Second Quarter 2024 Operating & Financial Results on August 8th, 2024 at 4:30 p.m. ET
Webcast to be held Thursday, August 8th, 4:30 p.m. ET, register for the webcast here, or at the link provided...
Live Ventures to Issue Fiscal Third Quarter 2024 Financial Results and Hold Earnings Conference Call on August 8, 2024
LAS VEGAS, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Live Ventures Incorporated (NASDAQ: LIVE) (“Live Ventures” or the “Company”), a diversified...
Linde Reports Second-Quarter 2024 Results (Earnings Release Tables Attached)
Second-Quarter Highlights Sales $8.3 billion, up 1%, underlying sales up 3% Operating profit $2.2 billion, adjusted operating profit $2.4 billion,...
Laureate Education Reports Financial Results for the Second Quarter and Six Months Ended June 30, 2024
MIAMI, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Laureate Education, Inc. (NASDAQ: LAUR), which operates five higher education institutions across Mexico...
Kura Oncology to Report Second Quarter 2024 Financial Results
SAN DIEGO, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing...
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Contacts KalVista Pharmaceuticals, Inc. Ryan Baker Head, Investor Relations (617) 771-5001 ryan.baker@kalvista.com KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that...
Itron Announces Second Quarter 2024 Financial Results
LIBERTY LAKE, Wash., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Itron, Inc. (NASDAQ: ITRI), which is innovating the way utilities and...
MiNK Therapeutics to Provide Corporate Update and Second Quarter 2024 Financial Report
NEW YORK, Aug. 01, 2024 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the discovery, development,...
Intelligent Bio Solutions Partners with CenExel to Conduct Clinical Study as Part of FDA 510(k) Pathway
NEW YORK, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical...
InflaRx to Report Second Quarter 2024 Results on August 8, 2024
JENA, Germany, Aug. 01, 2024 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting...
InterDigital Announces 2024 Investor Day
WILMINGTON, Del., Aug. 01, 2024 (GLOBE NEWSWIRE) -- InterDigital, Inc. (Nasdaq: IDCC), a mobile, video and AI technology research and...
IAS Appoints Industry Leader Bob Lord to its Board of Directors
NEW YORK, Aug. 2, 2024 /PRNewswire/ -- Integral Ad Science (Nasdaq: IAS), a leading global media measurement and optimization platform,...